Tuesday, November 30, 2010

Recent Resveratrol Research

Resveratrol is a phytochemical that is found in the skin of red grapes, red wine, chocolate, peanuts, blueberries, and cranberries. It also is produced by chemical synthesis derived primarily from grapes or Japanese knotweed and is sold as a nutritional supplement. Here is the most up-to-date research with our comment at the end.
  • The US Agricultural Research Service indicates resveratrol can both inhibit and promote the growth of prostate cancer cells – depending on the length of time cells are exposed to the compounds. Their study, published in the journal Carcinogenesis, says gauging the benefits of consuming these dietary compounds involves careful tracking of concentration, timing, and interactions with other compounds and more research needs to be done
  • Writing in the International Journal of Obesity, researchers report that resveratrol changed the production of certain compounds called adipokines from human fat cells, and produced an anti-inflammatory effect in-vitro. Single doses of orally administered resveratrol can modulate cerebral blood flow variables to enhance cognition (small study of 22 people).
  • A Journal of Clinical Endocrinology & Metabolism study showed suppression of inflammation in humans, A nutritional supplement containing 40 milligrams of resveratrol was used for 20 participants, randomized into two groups of 10: one group received the supplement, while the other group received an identical pill containing no active ingredient. Results showed that resveratrol suppressed the generation of free radicals and suppression of the inflammatory protein tumor necrosis factor (TNF) and other similar compounds that increase inflammation in blood vessels and interfere with insulin action. Blood samples from the participants who received the placebo showed no change in these pro-inflammatory markers.
  • A Journal Nutrition study looked at resveratrol's in-vitro effect on the BRCA-1 protein, a tumor suppressor involved in repair of DNA damage. Epigenetic mechanisms contribute to its reduced expression in sporadic breast tumors. Through diet, humans are exposed to a complex mixture of xenobiotics and natural ligands of the aromatic hydrocarbon receptor (AhR), which contributes to the etiology of various types of cancers. Preliminary testing supports the hypothesis that epigenetic silencing of the BRCA-1 gene by the AhR is preventable with resveratrol and provides the molecular basis for the development of dietary strategies based on natural AhR antagonists.
  • A study published in Nutrition, Metabolism & Cardiovascular Diseases evaluated the acute effects of oral resveratrol supplementation on circulatory function, revealing that resveratrol improves flow-mediated dilatation (FMD) - a marker of cardiovascular function - compared with placebo. The research compared supplements of 30, 90, and 270 mg resveratrol with placebo in 19 overweight or obese subjects.

  • GlaxoSmithKline formally terminated a clinical trial of an experimental drug designed to harness the potential health benefits of red wine, saying it had minimal efficacy in cancer patients and could potentially exacerbate kidney complications. The U.K. drug maker also reiterated that it isn't planning any further testing of the drug, SRT501 (a chemicalized resveratrol), because it is focusing on other compounds designed to work similarly to SRT501 but which differ chemically. GlaxoSmithKline obtained SRT501 with its $720 million purchase of Sirtris Pharmaceuticals in 2008.

Our Comment:
At this time, the sample size and number of participants for research on resveratrol supplements are not enough to warrant use in healthy individuals. In certain individuals with chronic disease, supplementation may be warranted under the supervision of a health professional. For healthy individuals, eating foods rich in resveratrol will suffice. Resveratol has phytoestrogenic effects which are contraindicated in certain individuals. Resveratrol is prevelant in salicylate foods, which is contraindicated for salicylate intolerant individuals.

Finally, new research has found that quercetin is prevelant in foods also high in resveratrol. While we know quercetin is effective without resveratrol, we do not know if resveratrol needs quercetin to have a therapeutic effect. Most resveratrol supplements do not contain quercetin. Recent data from the American Journal of Clinical Nutrition suggests quercetin is equally or more effective than resveratrol in attenuating inflammation and insulin resistance in primary human adipocytes.

No comments:

Post a Comment